A Complex Role of Activin A in Non-Alcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

A Complex Role of Activin A in Non-Alcoholic Fatty Liver Disease

Published:2009-06-16 Issue:9 Volume:104 Page:2196-2205
ISSN:0002-9270
Container-title:The American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Yndestad Arne,Haukeland John Willy,Dahl Tuva Børresdatter,Bjøro Kristian,Gladhaug Ivar Prydz,Berge Christ,Damås Jan Kristian,Haaland Terese,Løberg Else Marit,Linnestad Paul,Birkeland Kåre,Konopski Zbigniew,Halvorsen Bente,Berge Rolf Kristian,Aukrust Pål

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Link

http://www.nature.com/articles/ajg2009318.pdf

Reference42 articles.

1. Non-alcoholic fatty liver disease

2. Long-term follow-up of patients with NAFLD and elevated liver enzymes

3. Long term prognosis of fatty liver: risk of chronic liver disease and death

4. Steatohepatitis: A tale of two “hits”?

5. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of activin receptor 2 signalling ameliorates metabolic dysfunction–associated steatotic liver disease in western diet/L-NAME induced cardiometabolic disease;Biomedicine & Pharmacotherapy;2024-06

2. Antagonizing Activin A/p15INK4b Signaling as Therapeutic Strategy for Liver Disease;Cells;2024-04-08

3. Comprehensive meta-analysis reveals distinct gene expression signatures of MASLD progression;Life Science Alliance;2024-04-02

4. Activin A levels in metabolic dysfunction-associated steatotic liver disease associates with fibrosis and the PNPLA3 I148M variant;Scandinavian Journal of Gastroenterology;2024-04-02

5. Roles of Activin A and Gpnmb in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD);Diabetes;2023-11-07